Evidence map›Paper›PMID 29968868›Full record

ArticleThe Analyst2018

Towards mapping electrostatic interactions between Kdo

Christopher M Crittenden, Lindsay J Morrison, Mignon D Fitzpatrick, Allison P Myers, Elisa T Novelli, Jake Rosenberg, Lucas D Akin, Sorin Srinivasa, Jason B Shear, Jennifer S Brodbelt

Abstract read
In one paragraph

Article in The Analyst, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Polyproline peptide targetsCell reports. Physical science · 2024
    Article
  2. Defining principles that influence antimicrobial peptide activity against capsulatedProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Christopher M CrittendenDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Lindsay J MorrisonDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Mignon D FitzpatrickDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Allison P MyersDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Elisa T NovelliDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.ORCID http://orcid.org/0000-0002-4046-1229
Jake RosenbergDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Lucas D AkinDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Sorin SrinivasaDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.ORCID http://orcid.org/0000-0001-8741-2582
Jason B ShearDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.
Jennifer S BrodbeltDepartment of Chemistry, University of Texas at Austin, Austin, Texas 78712, USA. jbrodbelt@cm.utexas.edu.ORCID http://orcid.org/0000-0003-3207-0217
The University of Texas at Austin · US

Funding

UVPD-MS Characterization of LipopolysaccharidesR01GM103655 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRODBELT, JENNIFER S. · 2012 to 2019
$2.3M
NIGMS NIH HHS R01 GM103655
6 · The paper itself

Abstract

Cationic antimicrobial peptides (CAMPs) have been known to act as multi-modal weapons against Gram-negative bacteria. As a new approach to investigate the nature of the interactions between CAMPs and the surfaces of bacteria, native mass spectrometry and two MS/MS strategies (ultraviolet photodissociation (UVPD) and higher energy collisional activation (HCD)) are used to examine formation and disassembly of saccharolipid·peptide complexes. Kdo2-lipid A (KLA) is used as a model saccharolipid to evaluate complexation with a series of cationic peptides (melittin and three analogs). Collisional activation of the KLA·peptide complexes results in the disruption of electrostatic interactions, resulting in apo-sequence ions with shifts in the distribution of ions compared to the fragmentation patterns of the apo-peptides. UVPD of the KLA·peptide complexes results in both apo- and holo-sequence ions of the peptides, the latter in which the KLA remains bound to the truncated peptide fragment despite cleavage of a covalent bond of the peptide backbone. Mapping both the N- and C-terminal holo-product ions gives insight into the peptide motifs (specifically an electropositive KRKR segment and a proline residue) that are responsible for mediating the electrostatic interactions between the cationic peptides and saccharolipid.

Indexed as

Protein Interaction MappingAntimicrobial Cationic PeptidesLipopolysaccharidesMelittenMolecular WeightPeptidesTandem Mass SpectrometryUltraviolet RaysAntimicrobial Cationic PeptidesKdo2-lipid ALipopolysaccharidesMelittenPeptides

Identifiers

PMID29968868
PMCPMC6056329
OpenAlexW2809715428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.